UK Companies House feature
RUDIPHARM LIMITED
Cash
£25K
+354.1% vs 2021
Net assets
-£1M
-226.5% vs 2021
Employees
4
+33.3% vs 2021
Profit before tax
-£806K
-17.2% vs 2021
Profile
- Company number
- 09987370
- Status
- Active
- Incorporation
- 2016-02-04
- Last accounts made up
- 2024-09-30
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Net assets
3-year trend · vs UK Healthcare median
Accounts
3-year trend · latest 2022-09-30
| Metric | Trend | 2020-09-30 | 2021-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Turnover | — | — | — | |
| Operating profit | — | — | — | |
| Profit before tax | — | -£687,294 | -£805,606 | |
| Net profit | — | -£605,263 | -£805,606 | |
| Cash | — | £5,457 | £24,779 | |
| Total assets less current liabilities | — | -£355,684 | -£1,158,390 | |
| Net assets | — | -£355,684 | -£1,161,290 | |
| Equity | £249,579 | -£355,684 | -£1,161,290 | |
| Average employees | — | 3 | 4 | |
| Wages | — | — | — |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Kishens Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the original financial statements were authorised for issue.”
Significant events
- “Investments have been made post year end into acquiring and developing licences for the UK and overseas markets.”
- “The company has entered into strategic agreements and partnerships for the developmet of products and marketing authorization to alleviate the impact of these issues.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
1 active · 1 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| RUPRAI, Kalvinder | Director | 2016-02-04 | Jul 1969 | British |
Show 1 resigned officer
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| RUPRAI, Amarjit Singh | Director | 2016-02-04 | 2018-09-05 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Ruprai Group Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2021-07-07 | Active |
| Medpro Healthcare Ltd | Corporate entity | Shares 75–100%, Voting 75–100% | 2020-09-30 | Ceased 2021-07-07 |
| Mr Kalvinder Ruprai | Individual | Shares 75–100% | 2018-09-05 | Ceased 2020-09-30 |
| Mr Amarjit Singh Ruprai | Individual | Significant influence | 2016-04-07 | Ceased 2018-09-05 |
Filing timeline
Last 20 of 34 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-04-17 | AA01 | accounts | change account reference date company previous extended |
| 2026-04-01 | CS01 | confirmation-statement | confirmation statement with updates |
| 2026-04-01 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2025-11-04 | AA | accounts | accounts with accounts type full |
| 2025-10-13 | AAMD | accounts | accounts amended with accounts type full |
| 2025-08-28 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-08-26 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-06-15 | AA | accounts | accounts with accounts type full |
| 2023-08-17 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-06-27 | AA | accounts | accounts with accounts type unaudited abridged |
| 2022-09-02 | AA | accounts | accounts with accounts type micro entity |
| 2022-08-16 | CS01 | confirmation-statement | confirmation statement with updates |
| 2022-08-16 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2022-08-16 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2021-10-13 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-10-03 | AA | accounts | accounts with accounts type micro entity |
| 2020-12-13 | AA01 | accounts | change account reference date company previous shortened |
| 2020-12-13 | AA | accounts | accounts with accounts type micro entity |
| 2020-10-06 | CS01 | confirmation-statement | confirmation statement with updates |
| 2020-10-06 | CS01 | confirmation-statement | confirmation statement with no updates |
Credit score
Altman Z″ (private-firm) · reference 2022-09-30
-18.75
DISTRESS
Altman Z″
- Working capital / Total assets -1.617 × 6.56 = -10.61
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets -1.115 × 6.72 = -7.49
- Book equity / Total liabilities -0.617 × 1.05 = -0.65
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Composite activity score · components 0–100 · reference 2026-05-10
25
COLD
/ 100
- Filings velocity 50
- Capital events 0
- Officer churn 0
- Headcount trajectory 83
- Accounts trajectory 0
- 6 filing(s) in last 12 months
- Employees +33% YoY
- Net Assets -226% YoY